Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2022-10-24 17:58:30
Oslo, Norway, October 24, 2022 - Cipriano AS and Cipriano Invest AS, a 100%
owned subsidiary of Cipriano AS, have merged. As a result, 1,625,000 shares in
Nykode Therapeutics ASA have been transferred from Cipriano Invest AS to
Cipriano AS. Cipriano AS is 100% owned by primary insider Einar J. Greve, Deputy
Board Member of Nykode Therapeutics ASA.
Please see further details in attached document.